LENZ Therapeutics (LENZ) saw its stock price surge 5.24% during intraday trading following the announcement of its new consumer campaign, "Make It Vizzable," featuring Sarah Jessica Parker as the brand ambassador for VIZZ™, its FDA-approved eye drop for presbyopia.
The campaign highlights the convenience of VIZZ, a once-daily eye drop that restores near vision for up to 10 hours, offering an alternative to reading glasses. The involvement of a high-profile celebrity like Sarah Jessica Parker is expected to significantly boost brand awareness and consumer adoption.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments